In the Cox PH model, APOE-ε4 status was associated with a reduced risk for all-cause mortality (HR = 0.91, 95% CI: 0.83–0.99, p = .030), cancers (HR = 0.85, 95% CI: 0.73–0.99, p = .039) and other causes of mortality (HR = 0.79, 95% CI: 0.65–0.96, p = .014) in women only in the following 10-year follow-up. This evidence concerns the gene APOE and cancer.